Subscribe to Our Newsletter

Success! Now Check Your Email

To complete Subscribe, click the confirmation link in your inbox. If it doesn’t arrive within 3 minutes, check your spam folder.

Ok, Thanks

Investment

Biotech Market Rebound: Key Executive Moves, AstraZeneca's Drug Setback, and Expedition Funding News post image

Biotech Market Rebound: Key Executive Moves, AstraZeneca's Drug Setback, and Expedition Funding News

Point72's Steven Cohen Invests in Clinical-Stage Biotech Palisade Bio, Signaling Market Shift post image

Point72's Steven Cohen Invests in Clinical-Stage Biotech Palisade Bio, Signaling Market Shift

Biotech Briefing: Medicare Drug Pricing, Sarepta Clinical Update, and New VC Firm Launch post image

Biotech Briefing: Medicare Drug Pricing, Sarepta Clinical Update, and New VC Firm Launch

Rubicon Research IPO: Key Details and Market Expectations Ahead of Oct. 9 Launch post image

Rubicon Research IPO: Key Details and Market Expectations Ahead of Oct. 9 Launch

Legend Biotech Sees Shifting Institutional Holdings and Analyst Outlook post image

Legend Biotech Sees Shifting Institutional Holdings and Analyst Outlook

MapLight Therapeutics Targets $704.3M Valuation in US IPO to Fund CNS Drug Pipeline post image

MapLight Therapeutics Targets $704.3M Valuation in US IPO to Fund CNS Drug Pipeline

IO Biotech (IOBT) Receives 'Hold' Consensus from Analysts Amidst Clinical Development post image

IO Biotech (IOBT) Receives 'Hold' Consensus from Analysts Amidst Clinical Development

Bezos Warns of AI Investment Bubble, Foresees Transformative Impact on Industry and Future Healthcare Infrastructure post image

Bezos Warns of AI Investment Bubble, Foresees Transformative Impact on Industry and Future Healthcare Infrastructure

Biotech and Health Tech Drive Significant Healthcare Funding Rounds This Week post image

Biotech and Health Tech Drive Significant Healthcare Funding Rounds This Week

Rubicon Research to Launch Rs 1,377.5 Cr IPO, Bolstering Specialty Pharma R&D and Acquisitions post image

Rubicon Research to Launch Rs 1,377.5 Cr IPO, Bolstering Specialty Pharma R&D and Acquisitions

Rubicon Research IPO: Strong Fundamentals and US Market Expansion Drive Growth post image

Rubicon Research IPO: Strong Fundamentals and US Market Expansion Drive Growth

Rubicon Research Sets ₹1,377.50 Crore IPO, Subscription Opens October 9 post image

Rubicon Research Sets ₹1,377.50 Crore IPO, Subscription Opens October 9

PepGen Secures $100M Public Offering to Advance FREEDOM-DM1 Clinical Trials post image

PepGen Secures $100M Public Offering to Advance FREEDOM-DM1 Clinical Trials